TY - JOUR
TI - Bone marrow biopsy in low-risk monoclonal gammopathy of undetermined significance reveals a novel smoldering multiple myeloma risk group
AU - Bustoros, M.
AU - Kastritis, E.
AU - Sklavenitis-Pistofidis, R.
AU - Liu, C.-J.
AU - Hornburg, K.
AU - Kanellias, N.
AU - Kim, G.
AU - Liu, D.
AU - Gavriatopoulou, M.
AU - Marinac, C.R.
AU - Roussou, M.
AU - Migkou, M.
AU - Noonan, K.
AU - Reyes, K.
AU - Rivotto, B.
AU - Neuse, C.J.
AU - Ziogas, D.C.
AU - Laubach, J.
AU - Terpos, E.
AU - Anderson, K.C.
AU - Richardson, P.G.
AU - Ghobrial, I.M.
AU - Dimopoulos, M.A.
JO - American Journal of Hematology
PY - 2019
VL - 94
TODO - 5
SP - E146-E149
PB - Wiley-Liss, Inc.
SN - 0361-8609, 1096-8652
TODO - 10.1002/ajh.25441
TODO - M protein, area under the curve;  bone marrow biopsy;  cancer growth;  diagnostic test accuracy study;  follow up;  human;  human tissue;  Letter;  major clinical study;  monoclonal immunoglobulinemia;  multiple myeloma;  priority journal;  protein electrophoresis;  receiver operating characteristic;  risk assessment;  risk factor;  sensitivity and specificity;  biopsy;  bone marrow;  clinical trial;  disease free survival;  monoclonal immunoglobulinemia;  mortality;  multicenter study;  pathology;  smoldering multiple myeloma;  survival rate, Biopsy;  Bone Marrow;  Disease-Free Survival;  Follow-Up Studies;  Humans;  Monoclonal Gammopathy of Undetermined Significance;  Risk Factors;  Smoldering Multiple Myeloma;  Survival Rate
TODO - null
ER -